Robots, autonomous vehicles, virtual reality laboratories, and lab product e-commerce all brought in venture cash this week. This and much more in the week’s Boston tech news:
—Self-driving car startup Optimus Ride has raised $20 million of what it hopes to... Read more »
The road to every new drug approval is littered with the remains of earlier failures. Biopharmaceutical companies don’t like to talk about the failures. But it’s earnings season now, so some of them don’t have much choice.
Biogen’s (NASDAQ: BIIB)... Read more »
PayScale, a Seattle-based compensation data company, announced Thursday it is selling a majority stake in the business to private equity fund Francisco Partners for an undisclosed amount of funding. The deal terms value PayScale at $325 million, the company says.
People... Read more »
Online education company Coursera announced today it raised $103 million in a Series E equity funding round to expand the international reach of its coursework, degree offerings, and workforce training programs.
The fundraising round brings in new investor SEEK Group,... Read more »
Walmart has unveiled its “store of the future,” which uses artificial intelligence-enabled cameras to tip off employees when products need to be replenished on shelves or expired meat and produce needs to be replaced.
The “Intelligent Retail Lab,” or... Read more »
A pair of Seattle-based organizations want to harness big data to help combat a big global health problem: malaria.
Xinova, which operates a global innovation network to help people turn ideas into real-world products and services, said Thursday it’s seeking... Read more »
[Corie Lok and Frank Vinluan co-authored this article.] Whether they’re 3D printing human tissues, encoding data in DNA, or securing medical devices against cyber attacks, the finalists in the Innovation at the Intersection category of the Xconomy Awards San... Read more »
[Updated 1:49 p.m. ET. See below.] An experimental Gilead Sciences treatment for the severe fatty liver disease NASH failed to beat a placebo in Phase 3 testing—the second time the drug has failed in a late-stage clinical trial.
Gilead... Read more »
Houston—Men have long leveraged their networks to succeed in business, and the tech industry has been no exception. Women, finding themselves outside of the club, are now creating their own networks to do the same.
Katelyn O’Shaughnessy already had a... Read more »
The first short message went out over Arpanet, the precursor to the internet, 50 years ago this year—and it changed everything. Much of the change has been wonderful—as the internet has revolutionized communication, commerce, and access to information, in the process... Read more »
Later next month, the Midwest Growth Capital Symposium (MGCS) will kick off its 38th annual two-day event dedicated to showcasingthe region’s high-growth companies to a cadre of local and out-of-town investors.
During the symposium, 32 companies actively seeking funding... Read more »
Avidity Biosciences, a biotech developing drugs that deliver bits of RNA and DNA to cells to treat disease, has signed its first strategic pharmaceutical partner.
Eli Lilly (NYSE: LLY) is paying Avidity $20 million upfront—plus $15 million in equity—for the... Read more »
[Updated 4/25/19, 11 am CT. See below.] U.S. technology startups continue to pull in heaps of cash to try and stave off shortages of a crucial medical radioisotope.
NorthStar Medical Technologies said this week it closed a deal to... Read more »